Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7500+0.0180 (+2.46%)
At close: 09:17AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 8.58B
Enterprise Value 7.25B
Trailing P/E 11.46
Forward P/E 12.30
PEG Ratio (5 yr expected) 17.56
Price/Sales (ttm)2.15
Price/Book (mrq)1.91
Enterprise Value/Revenue 1.79
Enterprise Value/EBITDA 7.53

Trading Information

Stock Price History

Beta (5Y Monthly) 0.68
52-Week Change 313.49%
S&P500 52-Week Change 334.08%
52 Week High 30.8750
52 Week Low 30.5108
50-Day Moving Average 30.6072
200-Day Moving Average 30.7046

Share Statistics

Avg Vol (3 month) 32.12k
Avg Vol (10 day) 39.61k
Shares Outstanding 511.6B
Implied Shares Outstanding 611.85B
Float 88.18B
% Held by Insiders 130.31%
% Held by Institutions 132.19%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.04
Forward Annual Dividend Yield 45.06%
Trailing Annual Dividend Rate 30.28
Trailing Annual Dividend Yield 337.57%
5 Year Average Dividend Yield 42.49
Payout Ratio 451.42%
Dividend Date 3N/A
Ex-Dividend Date 4Oct 31, 2024
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 18.72%
Operating Margin (ttm)22.85%

Management Effectiveness

Return on Assets (ttm)9.86%
Return on Equity (ttm)17.34%

Income Statement

Revenue (ttm)31.65B
Revenue Per Share (ttm)2.67
Quarterly Revenue Growth (yoy)-9.00%
Gross Profit (ttm)N/A
EBITDA 8.24B
Net Income Avi to Common (ttm)5.93B
Diluted EPS (ttm)0.0600
Quarterly Earnings Growth (yoy)-8.50%

Balance Sheet

Total Cash (mrq)10.82B
Total Cash Per Share (mrq)0.92
Total Debt (mrq)388.87M
Total Debt/Equity (mrq)1.07%
Current Ratio (mrq)2.54
Book Value Per Share (mrq)2.95

Cash Flow Statement

Operating Cash Flow (ttm)4.28B
Levered Free Cash Flow (ttm)1.62B